Hospira Bleomycin Sulphate for Injection, USP 15 U, vial

Nazione: Australia

Lingua: inglese

Fonte: Department of Health (Therapeutic Goods Administration)

Principio attivo:

bleomycin sulfate, Quantity: 15000 IU

Commercializzato da:

Hospira Australia Pty Ltd

INN (Nome Internazionale):

bleomycin sulfate

Forma farmaceutica:

Injection, powder for

Composizione:

Excipient Ingredients:

Via di somministrazione:

Intraarterial, Intracavitary, Intramuscular, Intravenous, Subcutaneous

Confezione:

1 X 10 mL vial

Classe:

Medicine Listed (Export Only)

Tipo di ricetta:

Not scheduled. Not considered by committee

Indicazioni terapeutiche:

Squamous cell carcinoma: skin, larynx and paralarynx, penis, cervix and vulva. Lung cancer and cervical carcinoma. Lymphomas: Hodgkin's lymphoma (no longer treatable by bone marrow depressant agents) and non-Hodgkin's lymphoma including reticulum cell sarcoma and lymphosarcoma. Testicular Carcinoma: Embryonal cell carcinoma, choriocarcinoma, and teratocarcimona. Pleurodysis and pleural fluid accumulation. Renal carcinomas and soft tissue sarcomas.

Dettagli prodotto:

Visual Identification: A white to cream coloured lyophilised powder or plug; Container Type: Vial; Container Life Time: 2 Years

Stato dell'autorizzazione:

Listed (Export Only)

Data dell'autorizzazione:

2006-03-10